Resource Centers
- FDA Panel Backs Vigabatrin for Refractory Seizures but Urges Caution
- Reps Can Distribute Info About Off-Label Drug and Device Use, Says the FDA
- Poor Sleep Before Rhinovirus Exposure Linked to Lower Resistance to Illness
- Teens Commonly Refer to Health Risk Behaviors on Social-Networking Site
- Recalls & Warnings FDA Continues to Review Link Between Montelukast and Neuropsychiatric Effects
Psychiatry & Mental Health Journals
- Alcohol and Alcoholism
- BMC Psychiatry
- Brain
- Brief Treatment of Crisis Intervention
- Current Opinion in Psychiatry
- Health and Quality of Life Outcomes
- Journal of Pediatric Psychology
- Pain Management Nursing
- Personalized Medicine
- Pharmacotherapy
- PLoS Medicine
- Psychopharmacology Bulletin
- Schizophrenia Bulletin
- Social Cognitive and Affective Neuroscience
Medscape Community Resources
Find a Primary Care Physician to treat your patients' non-psychiatric medical needs.
(Sponsored by Lilly)
POLL
In a December online issue of the British Medical Journal, two medical experts debate whether oral contraceptives should or should not be sold as over-the-counter drugs. Do you favor or oppose making oral contraceptives available over the counter?
Expert Video Blogs
Advisory Board
- Kathleen Brady, PhD, MD
- James C.Y. Chou, MD
- Samuel Gershon, MD
- Eric Hollander, MD
- Paul E. Keck, Jr., MD
- Stephen R. Marder, MD
- Mark H. Pollack, MD
- William Sanderson, PhD
Editorial Director
